ResearchMedicine and treatment
Health news, 16 October 2026: an FDA approval in dMMR colon cancer, an oral IL-23 blocker, and a microRNA model after a positive FIT
Five events from the past two weeks: FDA approval of atezolizumab after surgery for stage III dMMR colon cancer, a phase 2 NEJM trial of oral icotrokinra in ulcerative colitis, a plasma microRNA model after a positive FIT, leg alignment after ACL surgery in teenagers, and biological age in 326,000 people.
8 min read